C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 501/16 (2006.01) A61K 31/545 (2006.01) A61K 31/695 (2006.01) A61K 31/70 (2006.01) A61K 47/48 (2006.01) C07D 519/00 (2006.01) C07F 7/10 (2006.01) C07H 15/252 (2006.01)
Patent
CA 2055062
ABSTRACT OF THE DISCLOSURE The instant invention relates to a novel method for the delivery of antitumor drugs to tumor cells by the administration of a tumor-selective antibody- .beta.- lactamase conjugate that binds to tumor cells, and the additional administration of a cephalosporin prodrug that is converted at the tumor site, in the presence of the antibody-.beta.-lactamase, to an active cytotoxic drug. According to the preferred embodiment of this invention, a cephalosporin mustard has been constructed which when cleaved by .beta.-lactamase yields a cytotoxic nitrogen mustard. The methods, antibody- enzyme conjugate, prodrugs, pharmaceutical compositions, and combinations of this invention provide for enhanced selective killing of tumor cells and are thus useful in the treatment of cancers and other tumors.
Kadow John
Kaneko Takushi
Senter Peter D.
Vrudhula Vivekananda M.
Barrigar & Moss
Bristol-Myers Squibb Company
LandOfFree
Prodrugs for beta-lactamase and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prodrugs for beta-lactamase and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prodrugs for beta-lactamase and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2074450